Showing results (11-20 of 402) with videos related to
Sort By:
Pageof 41
Plos Currents|March 2, 2012
Antiviral usage for H1N1 treatment: pros, cons and an argument for broader prescribing guidelines in the United StatesEdward Goldstein, Marc LipsitchPlos Currents|March 2, 2012
H1N1 vaccination and adults with underlying health conditions in the USEdward Goldstein, Marc LipsitchEpidemiology (Cambridge, Mass.)|February 1, 2024
Estimated Excess Deaths Due to COVID-19 Among the Urban Population of Mainland China, December 2022 to January 2023Leon Raphson, Marc LipsitchInterface Focus|September 29, 2025
Equity considerations in COVID-19 vaccine allocation modelling: a methodological studyEva Rumpler, Marc LipsitchClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposureNir Eyal, Marc LipsitchClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2021
How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is AvailableNir Eyal, Marc LipsitchScience (New York, N.Y.)|March 3, 2012
Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypesSarah Cobey, Marc LipsitchEpidemiology (Cambridge, Mass.)|June 17, 2008
Too little of a good thing: a paradox of moderate infection controlTed Cohen, Marc LipsitchProceedings of the National Academy of Sciences of the United States of America|April 17, 2025
Focusing a viral risk ranking tool on predictionKatherine Budeski, Marc LipsitchNEJM Evidence|May 30, 2024
Diagnostics for Public Health - Infectious Disease Surveillance and ControlMarc Lipsitch, Yonatan GradPageof 41